Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Russell M. Hagan
Observed names:
RUSSELL M. HAGAN,
Russell Hagan,
Russell M Hagan
Institutions:
Institute of Cancer Research,
National Institute for Health and Care Research,
NIHR Biomedical Research Centre at The Royal Marsden and the ICR,
BTG International (United Kingdom)
Observed institutions:
University of Leeds,
Institute of Cancer Research,
GlaxoSmithKline (United Kingdom),
National Institute for Health and Care Research,
NIHR Biomedical Research Centre at The Royal Marsden and the ICR,
BTG International (United Kingdom)
show all 6
OpenAlex ID:
A5110114834
Clinical development of new drug–radiotherapy combinations
2016
·
on behalf of the NCRI CTRad Academia-Pharma Joint Working Group
, Ricky A. Sharma
, et al.
·
Nature Reviews Clinical Oncology
·
345
PDF
Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats
1998
·
Eric Southam
, Debbie Kirkby
, et al.
·
European Journal of Pharmacology
·
138
Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder
1998
·
Xinmin Xie
, Russell Hagan
·
Neuropsychobiology
·
137
Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain
1987
·
Russell M. Hagan
, Arthur Butler
, et al.
·
European Journal of Pharmacology
·
116
Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model
2003
·
Sharon C Stratton
, Charles H Large
, et al.
·
Epilepsy Research
·
94
Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor
1992
·
Andrew B. McElroy
, Stephen P. Clegg
, et al.
·
Journal of Medicinal Chemistry
·
74
Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat
1992
·
Paul Overton
, Peter J. Elliott
, et al.
·
European Journal of Pharmacology
·
62
Development of Tolerance in Mice to the Sedative Effects of the Neuroactive Steroid Minaxolone Following Chronic Exposure
1997
·
Fiona H Marshall
, Sharon C Stratton
, et al.
·
Pharmacology Biochemistry and Behavior
·
56
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors
1995
·
Isabel J.M. Beresford
, Robert L.G. Sheldrick
, et al.
·
European Journal of Pharmacology
·
54
Modulation of the rat mesolimbic dopamine pathway by neurokinins
1992
·
Peter J. Elliott
, Glenn S. Mason
, et al.
·
Behavioural Brain Research
·
40
5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system
1995
·
Gavin J. Kilpatrick
, Russell M. Hagan
, et al.
·
Behavioural Brain Research
·
38
Conformationally constrained tachykinin analogs: potent and highly selective neurokinin NK-2 receptor agonists
1992
·
Martyn J. Deal
, Russell M. Hagan
, et al.
·
Journal of Medicinal Chemistry
·
37
Benserazide and carbidopa as substrates of catechol-O-methyltransferase: New mechanism of action in Parkinson's disease
1980
·
Russell M. Hagan
, Michael J. Raxworthy
, et al.
·
Biochemical Pharmacology
·
28
Depression of primary afferent‐evoked responses by GR71251 in the isolated spinal cord of the neonatal rat
1993
·
Jian‐Zhong Guo
, Koichi Yoshioka
, et al.
·
British Journal of Pharmacology
·
23
A rapid and transient synthesis of nitric oxide (NO) by a constitutively expressed type II NO synthase in the guinea‐pig suprachiasmatic nucleus
2001
·
Sarah J Starkey
, Andrea L Grant
, et al.
·
British Journal of Pharmacology
·
21
PDF
Broad spectrum anticonvulsant activity of BW534U87: possible role of an adenosine-dependent mechanism
2002
·
Eric Southam
, Sharon C Stratton
, et al.
·
Pharmacology Biochemistry and Behavior
·
19
Pharmacological characterization of GR82334, a tachykinin NK1 receptor antagonist, in the isolated spinal cord of the neonatal rat
1995
·
Jian-Zhong Guo
, Koichi Yoshioka
, et al.
·
European Journal of Pharmacology
·
19
Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo
2005
·
Eric Southam
, Rui Pereira
, et al.
·
European Journal of Pharmacology
·
15
Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of theC‐terminal hexapeptide of substance P: Structure‐activity relationships
1991
·
KOSTAS KARAGIANNIS
, AMALIA MANOLOPOULOU
, et al.
·
International journal of peptide & protein research
·
14
Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitude
1999
·
Willem J Drijfhout
, Jan B de Vries
, et al.
·
European Journal of Pharmacology
·
10
Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglion
1995
·
Anthony B. Hawcock
, Isabel J.M. Beresford
, et al.
·
European Journal of Pharmacology
·
10
Synthesis of a potent antagonist of substance P by replacing the CH2SCH3and the α‐carboxamide groups of the methionine al [Orn6]‐SP6–11by benzyl ester groups
1993
·
KOSTAS KARAGIANNIS
, GEORGE STAVROPOULOS
, et al.
·
International journal of peptide & protein research
·
10
Adenosine Al Receptor Agonist GR79236 Suppresses Apnea During All Sleep Stages in the Rat
1997
·
David W. Carley
, Russell M. Hagan
, et al.
·
SLEEP
·
8
Role of NK-2 receptors in the antidipsogenic activity of neurokinins in the mouse
1992
·
Delia M. Walsh
, Peter J. Elliott
, et al.
·
General Pharmacology The Vascular System
·
5
Synthesis of potent antagonists of substance P by modifying the methionyl and glutaminyl residues of its C‐terminal hexapeptide and without using d ‐amino acids
1993
·
AMALIA MANOLOPOULOU
, KOSTAS KARAGIANNIS
, et al.
·
International journal of peptide & protein research
·
4
Show more works
View as search
Works count:
30
Citation count:
1,381
H-index:
17
I10-index:
22
Year
Topic
Type